Dynavax Technologies reported $61.4M in Operating Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US USD 4.6B 1.31B
Adma Biologics ADMA:US USD 22.12M 31.29M
Agenus AGEN:US USD -41645000 2.92M
Amgen AMGN:US USD 2.23B 508M
AstraZeneca AZN:LN USD 1.25B 706M
Astrazeneca AZN:US USD 1.25B 706M
Biogen BIIB:US USD 1.32B 1.37B
Biomarin Pharmaceutical BMRN:US USD -2417000 41.57M
Bristol Myers Squibb BMY:US USD 1.94B 528M
Chimerix CMRX:US USD 11.65M 35.09M
Dynavax Technologies DVAX:US USD 61.4M 66.83M
Gilead Sciences GILD:US USD 2.27B 570M
Glaxosmithkline GSK:US GBP 1.87B 677M
Idera Pharmaceuticals IDRA:US USD -9327000 3.96M
Merk MRK:US USD 3.51B 505M
Minerva Neurosciences NERV:US USD -5207000 1.76M
Nektar Therapeutics NKTR:US USD -54301000 98.54M
Neurocrine Biosciences NBIX:US USD 87.8M 103.1M
Novartis NOVN:VX USD 2.17B 60M
Pfizer PFE:US USD 5.17B 4.24B
Regeneron Pharmaceuticals REGN:US USD 1.22B 113.8M
Roche Holding ROG:VX 11.55B 3.47B
Sarepta Therapeutics SRPT:US USD -256796000 45.66M
Tg Therapeutics TGTX:US USD -34963000 3.98M
Vertex Pharmaceuticals VRTX:US USD 1.13B 20.4M